Oxford Asset Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,615
| Closed | -$93.5K | – | 616 |
|
2024
Q4 | $93.5K | Buy |
+2,615
| New | +$93.5K | 0.04% | 396 |
|
2024
Q2 | – | Sell |
-663
| Closed | -$74.3K | – | 371 |
|
2024
Q1 | $74.3K | Buy |
+663
| New | +$74.3K | 0.08% | 232 |
|
2020
Q1 | – | Sell |
-8,065
| Closed | -$1.16M | – | 868 |
|
2019
Q4 | $1.16M | Buy |
8,065
+981
| +14% | +$140K | 0.03% | 772 |
|
2019
Q3 | $280K | Buy |
7,084
+1,441
| +26% | +$57K | 0.01% | 1481 |
|
2019
Q2 | $571K | Buy |
+5,643
| New | +$571K | 0.01% | 1219 |
|